PR
Profound Medical Corp.
PRN.TO · TSX
$9.54 +1.06% (+$0.10)
1M -7.38%
Market Cap $248.8M
P/E Ratio -
Div. Yield -
ROE 62.45%
Piotroski F-Score Weak
3/9Valuation
19 /100
Expensive P/S 13.11x
P/B 5.00x
P/E N/A
Growth
93 /100
Growing Rev. growth 34.84%
Book val. growth 8.11%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 71.73%
Net margin 170.92%
Op. margin 184.35%
Quality
4 /100
Poor ROIC 60.91%
ROE 62.45%
ROA 52.05%
Debt
100 /100
Low Debt/Equity 0.15x
Current ratio 6.46x
Int. coverage N/A
Stability
56 /100
Moderate Beta 0.50x
Rev. volatility 25.01%
EPS volatility 22.77%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRN.TO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Arun Swarup Menawat
Employees
162
Headquarters
Mississauga
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report